Proactive Investors -- EDAP TMS SA (NASDAQ:EDAP), a developer of medical devices based in Vaulx-en-Velin, France, announced today that it has received approval from the South-Korean Food and Drug Administration for its new lithotripter, Sonolith i-move.
